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ABSTRACT 
 
Eph receptor tyrosine kinases and their ligands, the ephrins, regulate the development 
and maintenance of multiple organs but little is known about their potential role within the 
cornea. The purpose of this study was to perform a thorough investigation of Eph/ephrin  
expression within the human cornea including the limbal stem cell niche. Initially, 
immunohistochemistry was performed on human donor eyes to determine the spatial 
distribution of Eph receptors and ephrins in the cornea and limbus. Patterns of Eph/ephrin 
gene expression in (1) immortalised human corneal endothelial (B4G12) or corneal epithelial 
(HCE-T) cell lines, and (2) primary cultures of epithelial or stromal cells established from the 
corneal limbus of cadaveric eye tissue were then assessed by reverse transcription (RT) PCR. 
Limbal epithelial or stromal cells from primary cultures were also assessed for evidence of 
Eph/ephrin-reactivity by immunofluorescence. Immunoreactivity for ephrinA1 and EphB4 
was detected in the corneal endothelium of donor eyes. EphB4 was also consistently detected 
in the limbal and corneal epithelium and in cells located in the stroma of the peripheral 
cornea.  Expression of multiple Eph/ephrin genes was detected in immortalised corneal 
epithelial and endothelial cell lines. Evidence of Eph/ephrin gene expression was also 
demonstrated in primary cultures of human limbal stromal (EphB4, B6; ephrinA5) and 
epithelial cells (EphA1, A2; ephrinA5, B2) using both RT-PCR and immunofluorescence. The 
expression of Eph receptors and ephrins within the human cornea and limbus is much wider 
than previously appreciated and suggests multiple potential roles for these molecules in the 
maintenance of normal corneal architecture.  
 
KEY WORDS: Eph; ephrin; cornea; limbus; human  
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1.  INTRODUCTION   
 
The optical properties of the cornea are dependent upon maintenance of a highly 
ordered tissue structure. Thus, conditions or diseases that disrupt normal corneal structure are 
invariably associated with vision loss (Cameron, 1983; Chang et al, 2001; Rabinowitz, 1998). 
The molecular mechanisms that establish and maintain normal corneal structure are, 
however, still not completely understood. This knowledge gap has lead us to consider the 
potential role of the Eph family of receptor tyrosine kinases and their ephrin ligands, since 
these molecules play important roles in establishing and maintaining tissue architecture 
within many organs (Egea and Klein, 2007; Pasquale, 2005). Eph receptors are the largest 
family of receptor tyrosine kinases but in contrast to other receptor tyrosine kinases which 
bind to soluble ligands, the ephrin ligands for Ephs are typically bound to the cell membrane 
of neighbouring cells (Davis et al, 1994). Two sub-families of Eph/ephrin molecules have 
been identified based upon shared structural or ligand binding properties. Generally, EphA 
receptors (EphA1-9) preferentially recognise ephrinA ligands that are bound to the cell 
surface via a glycosylphosphatidylinositol (GPI) anchor. Conversely, EphB receptors 
(EphB1-B4, B6) bind to transmembrane ephrinB ligands (ephrinB1-B3). Each mechanism 
allows for precise cell-cell signalling in a spatiotemporal manner. Activation of Eph/ephrin 
signalling pathways has been implicated in a variety of developmental and pathological 
processes via effects on tissue morphogenesis, cell migration, angiogenesis, cellular 
differentiation and tumour formation (Hafner et al, 2004; Kullander and Klein, 2002; 
Ruoslahti, 1999; Surawska et al, 2004).  
 
The eye has been previously examined as a model of potential Eph/ephrin 
interactions, with the overwhelming majority of these studies focussed on the retina. For 
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example, it has been reported that EphAs induce the collapse of growth cones and axon 
retraction in cultures of retinal ganglion cells (Knoll and Drescher, 2004). Likewise, there is 
convincing evidence that complimentary gradients of EphA receptors and ephrinA ligands 
are critical to the formation of topographic maps for the retina and superior colliculus (Knoll 
et al, 2001). Of the relatively few investigations conducted into Eph/ephrin molecules in the 
cornea, the majority have been concerned with aberrant growth of blood vessels (Kojima et 
al, 2007a; Kojima et al, 2007b). For example, EphB1-Fc chimeras induce neovascularisation 
in a mouse corneal micropocket assay (Huynh-Do et al, 2002). Likewise, 
immunohistochemical studies have provided evidence that EphB1 and ephrinB1 play 
important roles in regulating fibroblast growth factor (FGF) induced corneal angiogenesis 
(Kojima et al, 2007b). In addition, it has been shown that elevated ephrinB2 expression 
enhances the growth of blood vessels over the mouse cornea in vivo (Maekawa et al, 2003). 
Recently, evidence has emerged that EphA2 suppresses corneal epithelial cell migration 
when stimulated by ephrinA1 ligand (Kaplan et al, 2012). Nevertheless, there remains a 
general paucity of data available regarding the expression patterns and potential functions of 
Eph/ephrin molecules within the cornea. The purpose of this investigation was therefore to 
perform a comprehensive study of Eph/ephrin expression within the human cornea. Data 
concerning the spatial distribution of Eph receptors and ephrin ligands within the cornea and 
limbus of donor eyes was assessed by immunohistochemistry. Patterns of Eph/ephrin gene 
expression were then determined in primary cultures of limbal stromal cells and epithelial 
cells as well as immortalised ocular cell lines. The results of this study demonstrate a much 
wider expression profile for Eph/ephrins within the anterior segment of the eye than has been 
previously appreciated. In particular novel findings are reported with respect to the corneal 
endothelium which may have important implications for future studies of this tissue. 
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2. MATERIALS AND METHODS  
 
2.1 Ocular tissue 
 Human ocular tissue was used after acquiring donor consent and ethics approvals 
from the Princess Alexandra Hospital and the Queensland University of Technology (ref: 
0800000807). The tissue was received as whole eyes, intact corneoscleral caps (the cornea 
and 1-2 mm of scleral rim), or as corneoscleral rims produced during penetrating 
keratoplasty. Caps were provided by the Queensland Eye Bank, Queensland Health. Rims 
were collected post-surgery from the Queensland Eye Centre. The ocular tissue was from 
both male and female donors aged between 65-85 years and was fixed in formalin 
immediately following receipt within two days of death  for use in immunohistochemistry or 
stored in Optisol (Bausch & Lomb, Inc. Rochester, NY, USA)  for between one and four days 
before being used to establish primary cell cultures. 
 
2.2 Cell Culture  
2.2.1 Immortalised human ocular cell lines 
Profiles of Eph/ephrin gene expression were characterised in  immortalised human 
cell lines derived from the corneal epithelium (HCE-T; Riken Cell Bank) or corneal 
endothelium (B4G12; a gift from Dr Monika Valtink) and cultured as described previously 
(Harkin et al, 2011; Madden et al, 2011).  An immortalised retinal pigment epithelial cell line 
(ARPE-19; ATCC Cat No. CRL-2302) was also included in this study as a example of a cell 
line derived from ocular tissue known to express Eph/ephrins (Dunn et al, 1996; Tian et al, 
2005). HCE-T cell cultures were propagated in DMEM High Glucose (Invitrogen, Mulgrave, 
VIC, Australia) supplemented with 10% foetal bovine serum (FBS; Thermo Scientific, 
Scoresby, VIC, Australia), 1% penicillin/streptomycin (PS) and 400 μM L-glutamine (both 
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Invitrogen. The B4G12 cell line was cultured in Opti-MEM-I media (Invitrogen) 
supplemented with 8% FBS, 5 ng/mL EGF, 20 ng/mL NGF, 100 μg/mL bovine pituitary 
extract, 20 μg/mL ascorbic acid, 200 μg/mL CaCl2 and 0.08% chondroitin sulphate (all from 
Invitrogen) (Madden et al, 2011). ARPE-19 cells were cultured in a 1:1 mixture of 
DMEM/F12 [ATCC; Cat. No. 30-2006] supplemented with 2.5 mM L-glutamine, 1.5 g/L 
sodium bicarbonate and 10% FBS [ATCC; Cat. No. 30-2020]. Immortalised cell lines were 
seeded (1 x 105 cells) into T75 culture flasks (Iwaki, Crown, Scientific, Minto, NSW, 
Australia) and fed with fresh media every 3 days until approximately 80-90% confluency was 
achieved. Cultures were incubated at 37oC with 5% CO2/95% atmospheric air for the duration 
of the culture period. 
 
2.2.2 Primary human limbal cell cultures 
Human limbal epithelial (HLE) cells in 3T3 co-culture: HLE cells for this study were established 
with or without serum supplement and murine 3T3 fibroblasts (ATCC; CCL-92, Manassas, VA, 
USA) as feeder cells.  Isolation and phenotyping of human HLE cells was performed as described 
previously (Ainscough et al, 2011). HLE cell cultures (passage p0 or p1) obtained from human 
donors (n=3) were established in T75 culture flasks in DMEM supplemented with 10% FBS 
as described previously (Ainscough et al, 2011).  Murine 3T3 fibroblasts required for co-
culture with HLE cells were also initially propagated in DMEM supplemented with 10% 
FBS. Immediately prior to co-culture with HLE cells, 3T3 fibroblasts were gamma-irradiated 
(2 x 25 gray) to inhibit further proliferation. Primary HLE cell cultures were established in 
T75 culture flasks by seeding freshly isolated cells (1 x 105 cells) in the presence of 2 x 106 
irradiated 3T3 feeder cells and provided with fresh media every 3 days until approximately 
80-90% confluency was achieved. Cell cultures were incubated at 37 oC with 5% CO2/95% 
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atmospheric air. For control purposes, cultures of murine 3T3 fibroblasts without HLE cells 
were also established.  
 
 
Human limbal epithelial cells (3T3, serum-free): HLE cell cultures were also established in 
serum-free medium in the absence of 3T3 cells.  Specifically, HLE cell cultures (n=3) were 
established using Defined Keratinocyte Serum-Free Medium (DK-SFM; Invitrogen) 
containing 1% PS solution (Bray et al, 2011). Primary HLE serum-free cell monocultures 
were established in T75 culture flasks by seeding freshly isolated cells (1 x 105 cells) that 
were provided with fresh media every 3 days for 14 days. Cell cultures were incubated at 
37oC with 5% CO2/95% atmospheric air. 
 
Human limbal stromal (HLS) cells: HLS cells were isolated from human donors (n=3). 
Isolation and phenotyping of human HLS cells was performed as described previously 
(Ainscough et al, 2011).  Briefly, HLS cultures prepared by methods used in the current study 
displayed a range of phenotype markers for fibroblasts and myofibroblasts (CD90, vimentin, 
alpha smooth muscle actin) but were negative for markers of neuronal cells (CD271), blood 
cells (CD45), endothelium (CD141; CD34) or epithelial cells (CD141). HLS cultures (passage 
(p) 0 or p1) were propagated in DMEM/F12 + GlutaMAX (Invitrogen) supplemented with 
10% FBS and 1% PS solution. Primary HLS cell cultures were established in T75 culture 
flasks by seeding freshly isolated cells (1 x 105 cells) that were provided with fresh media 
every 3 days until approximately 80-90% confluency was achieved. Cell cultures were 
incubated at 37 oC with 5% CO2/95% atmospheric air. 
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2.3 Immunohistochemistry  
2.3.1 Donor corneas 
Corneas from human donors (n=3) were fixed in 10% formalin, dehydrated in increasing 
concentrations of ethanol and then embedded in paraplast (SPI Supplies, West Chester, PA, USA). 
Briefly, sections were cut at 3 µM on a rotary microtome (LKB, Bromma, Sweden). To reduce 
nonspecific immunoreactivity, de-waxed, rehydrated tissue sections were pre-incubated with 
endogenous peroxidise blocking agent (Dako Australia Pty Ltd, Campbellfield, NSW, Australia) and 
2% bovine serum albumin (BSA; Sigma-Aldrich, Castle Hill, NSW, Australia) in phosphate 
buffered saline (PBS; pH 7.0-7.2; Invitrogen). Following three brief rinses in PBS, sections were 
incubated overnight at 4oC with the appropriate primary antibody diluted in PBS-BSA. Primary 
antibodies for members of the Eph/ephrin family (Invitrogen; BenEphex Biotechnologies Pty, Ltd, 
Adelaide, SA, Australia; R&D Systems, Minneapolis, MN, USA; Abcam, Cambridge, MA, 
USA) used for this study are summarised in Table 1.  Primary antibody omission was used as a 
negative control. Primary antibody specificity was further confirmed by preincubation overnight at 
4oC with the corresponding antigenic peptide (Invitrogen) prior to use.  
 
Primary antibodies to the Cytokeratin pair K3/K12 (Chemicon, Millipore, North Ryde, NSW, 
Australia) and nuclear transcription factor Np63 (Biolegend, Australian Biosearch, Karrinyup, 
WA, Australia) were used to confirm the presence of a normal differentiated layer of corneal 
epithelium, along with a normal complement of limbal epithelial progenitor cells, respectively (Di 
Iorio et al, 2005; Schermer et al, 1986).  
 
Following overnight incubation with primary antibodies, sections were rinsed briefly with 
three changes of PBS then incubated with anti-rabbit/anti-mouse peroxidase labelled polymer (Dako 
Australia Pty Ltd, Campbellfield, NSW, Australia) for 20 minutes at room temperature. Sections were 
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then rinsed in PBS as before, after which liquid diaminobenzidine (DAB) substrate chromogen 
(Dako Australia Pty Ltd, Campbellfield, NSW, Australia) was applied to visualise immunoreactivity 
(IR). After counterstaining with Mayer’s haematoxylin, sections were dehydrated in increasing 
concentrations of ethanol, then examined by bright field microscopy using an Olympus BX41 
microscope (Olympus, Tokyo, Japan) equipped with a Nikon DXM-1200 colour device 
camera (Nikon, Tokyo, Japan) and NIS-Elements imaging software (Ver. 3.20). To further 
confirm the histological integrity of donor tissue, additional serial sections were stained with 
haematoxylin and eosin. 
 
2.3.2 Primary limbal cells 
Cells from primary cultures of HLE+3T3 or HLS cells were seeded onto glass 
coverslips (12mm diameter; Pro.Sci. Tech, Thuringowa, QLD, Australia) in 24 well tissue 
culture plates (Iwaki) at a density of 8 x 103 cells/well in 0.5 mL DMEM supplemented with 
10% FBS (HLE+3T3 cells) as described previously (Ainscough et al, 2011) or 0.5 mL  
DMEM/F12 + GlutaMAX (Invitrogen, Mulgrave, VIC, Australia) supplemented with 
10% FBS and 1% PS solution (HLS cells). Cultures were incubated at 37oC for four days 
with 5% CO2/95% atmospheric air. At the completion of the culture period, cells were rinsed 
briefly in PBS then fixed in 5% formalin for 5 minutes before washing twice again briefly in 
PBS. Cells were then permeabilised with 0.05% Triton X-100 for 5 minutes, rinsed twice 
with PBS then incubated with 1% non-immune serum in PBS for 30 minutes at room temperature to 
reduce non-specific binding. Following two brief rinses in PBS, sections were incubated for two 
hours at room temperature with the appropriate primary antibody diluted in 1% PBS-BSA. Primary 
antibodies for members of the Eph/ephrin family used for this study are summarised in Table 1.  
Following three brief rinses in PBS, detection of IR was performed by incubating cells on coverslips 
with an Alexa Fluor 488 donkey anti-goat or anti-mouse, or an Alexa Fluor 594 anti-rabbit antibody 
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(Invitrogen) at a concentration of 1/200 in 1% PBS-BSA for one hour at room temperature. Hoechst 
33342 nucleic acid stain (Invitrogen) was used to counter stain nuclei.   
 
2.4 Reverse Transcription - Polymerase Chain Reaction (RT-PCR) 
2.4.1 RNA isolation: Cultured corneal cells were processed for RNA extraction using methods 
described previously (Chomczynski and Sacchi, 1987). Briefly, cultured cells were lysed with 1 
mL TRIzol® reagent (Invitrogen) then incubated with chloroform (200 µL/mL lysate) for 2 minutes at 
room temperature. After centrifugation at 12,000 g for 15 minutes at 4 oC, the aqueous phase was 
added to isopropyl alcohol (0.5 mL/mL lysate) and incubated for 10 minutes at room temperature. 
Following centrifugation at 12,000 g for 10 minutes at 4 oC, the supernatant was removed and the 
RNA pellet washed with 1 mL 75% ethanol. Samples were then centrifuged at 7,500 g for 5 minutes 
at 4 oC, the RNA pellet was resuspended with 30 µL ultrapure distilled water (Invitrogen) and stored 
at -80 oC. Estimation of RNA content was obtained by spectrophotometric analysis using the ND-
1000 (Thermo Scientific, Florida, USA) spectrophotometer and A260/A280 and A260/A230 ratios 
calculated to estimate RNA purity.  
 
2.4.2 Reverse Transcription (RT): RT was performed by combining 2 µg sample RNA, 1 µL 
random primers (pd(N)6), 1 µL dNTPs (125 nM; both from Promega, Madison, WI, USA), and 
ultrapure distilled water to give a total volume of 10 µL. The mixture was incubated for 5 minutes at 
65 oC. Subsequently, 2 µL 5x first strand RXN buffer, 4 µL MgCl2 (25mM), 2 µL DTT (0.1M), 1 µL 
RNAase OUT (40U/µL), and 1 µL Superscript III (200 U/µL; all  Invitrogen) was added and samples 
were incubated for 10 minutes at 25 oC, 1 hour at 55 oC then 15 minutes at 70 oC. Samples containing 
cDNA were stored at -20 oC. To demonstrate the specificity of the RT reaction, additional samples of 
RNA from all donors were processed for RT without the addition of Superscript III (negative 
controls).  
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2.4.3 Polymerase Chain Reaction (PCR): PCR analysis was performed by combing 2 µL sample 
cDNA with 5 µL 10x PCR buffer, 1 µL MgCl2 (0.5 mM; both from Invitrogen), 1 µL dNTPs (0.2 
mM), 1 µL forward primer, 1 µL reverse primer (both from Promega), 1 µL HotStar Taq polymerase 
(0.5 U; Qiagen, Doncaster, VIC, Australia), and 38.9 µL ultrapure distilled water. A summary of 
primers used in this study is shown in Table 2. The PCR reaction was initiated by incubation at 
94oC for 2 minutes. This was followed by 35 cycles of: 1) 94oC for 30 seconds, 2) 62oC for 
30 seconds and, 3) 72oC for 30 seconds. After a final incubation at 72oC for 7 minutes, PCR 
product was applied to a 2% agarose gel containing 0.003% ethidium bromide. In addition to 
primary corneal cell lines, a positive control of HCE-T cell line or prostate cell lines (BPH-1, 
C42B, LNCaP, PC3, 22RV-1 VO, 22RV-1 VWT, or 22RV-1 B4; ATCC, Rockville, MD, 
USA) was employed in each agarose gel. Product band sizes were estimated by comparison 
with DNA molecular weight marker X (0.075 – 12.21 kbp; Roche, Castle Hill, NSW, 
Australia). Electrophoresis was performed at 100 mV in Tris/Borate/EDTA buffer (1X TBE; 
89 mM Tris-borate, 89 mM boric acid, 2mM EDTA, pH 8.3). Human β2-microglobulin 
controls were employed to confirm cDNA integrity and ensure that approximately equivalent 
amounts of cDNA were added to each PCR reaction. Experiments were conducted in 
triplicate. RT-PCR results are reported as positive only when there was no evidence of 
product produced in corresponding negative controls (i.e. no reverse transcriptase or water 
blanks). To confirm the identity of product bands, DNA corresponding to amplified cDNA 
products was extracted from agarose gels using the Wizard® SV Gel and PCR Clean-Up 
System  (Promega).  Samples were sent for sequencing by the Australian Genome Research 
Facility, Brisbane, Australia. 
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3. RESULTS 
 
3.1 Immunohistochemistry: Donor corneas 
 
3.1.1 Examination of tissue morphology: Prior to studying the potential distribution of Eph/ephrin 
molecules we examined the general morphology of donor tissue, and especially the integrity of the 
corneal epithelium, to ensure that samples being studied had not been significantly damaged during 
organ retrieval and subsequent storage and handling. Immunohistochemistry using antibodies to 
cytokeratin K3/K12 and ∆Np63 was conducted to confirm the preservation of corneal 
epithelium and limbal epithelial progenitor cells, respectively. Intense immunoreactivity (IR) 
for cytokeratin K3/K12 was detected throughout the cytoplasm of cells within the superficial 
aspect of the corneal epithelium confirming the differentiated corneal epithelial cell 
phenotype (Fig. 1A). Basal cells of the limbal epithelium exhibited strong reactivity for 
∆Np63 suggesting the presence of putative stem cells (Fig. 1C). No evidence of ∆Np63-IR 
was detected in any other region of the cornea above that seen in negative control sections 
(Fig. 1D).  
 
3.1.2 Eph/ephrins: Of all the Eph/ephrin antibodies tested (Table 1), only those raised 
against ephrinA1 or EphB4 consistently displayed significant IR in all donor samples. 
EphrinA1-IR was localised exclusively to the endothelium of donor corneas (Fig. 2B). 
Interestingly, ephrinA1-IR appeared to be localised to the cytoplasm of endothelial cells and 
was evident in both the central and peripheral regions of the cornea. By contrast, no evidence 
of ephrinA1-IR was detected elsewhere in the cornea or limbus (Fig. 2C). EphB4-IR was 
consistently detected throughout the epithelium of the limbus (Fig. 3D) and the corneal 
endothelium (Fig. 3F) in all donor samples tested using either primary antibody (C1 or 13A7) 
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at a concentration of 1:3200. The most intense EphB4-IR in limbal epithelium was detected 
at junctions between individual epithelial cells (Fig. 3D). By contrast, the EphB4-IR detected 
in the corneal endothelium appeared to be predominantly localised to the cytoplasm (Fig. 3F). 
Examination of the peripheral stroma of the cornea also revealed cells located between 
collagenous lamellae that displayed intense EphB4-IR (Fig. 3E) using primary antibody at a 
concentration of 1:400.  
 
3.2 Eph/ephrin gene expression in human ocular cells 
 
3.2.1 Immortalised cell lines: As summarised in Table 3, expression of multiple Eph/ephrin 
genes was detected in immortalised cultures of corneal epithelial cells (HCE-T: EphA1-3, B2, 
B4, B6; ephrinA2, A3, A5, B2), corneal endothelial cells (B4G12; EphA2, A3, A5, B2, B4, B6; 
ephrinA2, A3, A5, B2) and retinal pigment epithelial cells (ARPE-19; EphA2, A3, A5, B1, B2, 
B4; ephrinA2, A3, A5, B2). A representative agarose gel obtained after performing RT-PCR 
analysis on immortalised cell lines (for ephrinA5) is shown in Fig. 4.  
 
3.2.2 Primary limbal cell cultures: Primary HLE cultures established in the presence of 3T3 
cells and serum typically achieved 80-90% confluency within 14 days of culture and 
displayed a characteristic epithelial cobblestoned morphology (Fig. 5A). By contrast, HLE 
cultures rarely achieved confluency in the absence of 3T3 cells and serum, unless grown in 
the presence of a commercial serum-free medium with growth supplements. Primary HLS 
cells cultured in the presence of serum generally achieved approximately 80-90% confluency 
within 14 days of culture and displayed a spindle shaped morphology (Fig. 5B).  
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 A summary of Eph/ephrin gene expression detected in primary cultures of limbal 
epithelial cells or stromal cells is shown in Table 3. A representative complete agarose gel 
obtained after performing RT-PCR analysis (for ephrinA5) on a primary cell culture 
(HLE+3T3) is shown in Fig. 6. Results which showed evidence of Eph/ephrin gene 
expression are summarised as a composite figure (Fig. 7) indicating relevant products from 
individual RT-PCR reactions.  
 
As shown in Fig. 7, evidence of EphA gene expression was detected in primary HLE 
cultures. Specifically, EphA1 transcripts were detected in all three HLE+3T3 samples. Faint 
product bands were also detected for EphA2 in HLE+3T3 cultures established from two of 
the three donors.  EphrinA5 expression was consistently detected in primary cultures of 
HLE+3T3 cells or HLS cells (Table 3, Figs. 6 and 7). It is important to note that although 
ephrinA5 expression was detected in monocultures of 3T3 fibroblasts (Fig. 7), ephrinA5 
transcripts were also detected in HLE cultures established in the absence of 3T3 feeder cells 
for two of the three donor samples (Table 3; Fig. 7).  
 
Evidence of EphB4 and EphB6 gene expression was detected in HLS cultures 
established from all donor samples tested (Table 3, Fig. 7). By contrast, there was no 
evidence of EphB gene expression in samples obtained from either 3T3 monocultures or 
cultures containing HLE cells, with the exception of one donor sample (donor 1) which 
displayed product for EphB4 when cultured in the absence of 3T3 cells. 
  
A consistent finding of this study was the detection of transcripts for ephrinB2 in all 
HLE and HLS primary cultures tested (Table. 3, Fig. 7). By contrast, RT-PCR analysis of 
3T3 monocultures failed to detect any significant evidence of ephrinB gene expression. 
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Expression of human β2-microglobulin was also obtained in all human primary cell cultures, 
but not in the murine 3T3 monocultures (Table. 3, Fig. 7).  
  
  
3.3 Immunocytochemistry: Primary limbal cultures 
  In instances where evidence of Eph/ephrin expression was detected in primary 
cultures of HLE+3T3 or HLS cells, immunofluorescence was conducted to confirm the 
presence of Eph/ephrin proteins. Images obtained of Eph/ephrin-IR were then overlayed with 
the appropriate Hoechst stained counterparts to indicate cell nuclei.  
 
As shown in Fig. 8, reactivity for EphA1, EphA2, ephrinA5 and ephrinB2 was consistently 
detected in HLE cell cultures prepared from all three donors. Immunoreactivity was most evident 
where HLE cells had formed small confluent clusters (Figs.  8C-F). Typically, Eph/ephrin-IR 
appeared as diffuse extranuclear staining. However, as shown in Fig. 8D intense EphA2-IR was also 
detected at borders between individual epithelial cells. 
 
Immunofluorescence performed on primary HLS cultures revealed immunoreactivity for 
EphB4, EphB6 and ephrin A5 (Fig. 9). Extranuclear EphB4-IR (Fig. 9D) and ephrin A5-IR (Fig 9F) 
was widely detected throughout HLS cell cultures. By contrast, EphB6-IR was detected in only a 
relatively small number of cells sparsely scattered throughout the culture (Fig. 9E). No evidence of 
ephrin B2-IR was observed in HLS cultures prepared from any of the three donors suggesting that 
mRNA is not translated in this case. An interpretation of this finding is that the expression of 
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ephrinB2 in HLS cells is not resulting in the translation of detectable protein. All negative controls for 
HLE or HLS cultures failed to show any significant staining (Figs. 8A, B Figs. 9A-C).  
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4.  DISCUSSION  
 
Despite having an established role in the development and pathology of several 
organs and tissues, including the retina, relatively little data is available on the distribution 
and potential function of Eph/ephrin proteins within the normal human cornea. Utilising 
intact tissue or cultured cells derived from the human cornea or limbus we screened for 
evidence of Eph/ephrin-IR and gene expression by immunohistochemistry and RT-PCR, 
respectively. In the first section of this study, the presence of EphB4 and ephrin A1-IR was 
demonstrated in tissues of the ocular surface. Subsequently, the expression of multiple 
Eph/ephrins was detected in transformed ocular cells and in cells derived from primary 
cultures of human limbal epithelial or stromal cells.  
 
A novel finding was detection of immunoreactivity for both EphB4 and ephrinA1 in 
the corneal endothelium of donor tissue whereas there was only expression of EphB4 in the 
B4G12 endothelial cell line. This  finding may have potentially important implications for 
understanding regulation of cell activity in the corneal endothelium. For example, the corneal 
endothelium exhibits low rates of mitosis in vivo, with cells typically arrested in G1 phase of 
the cell cycle (Joyce et al, 1996). Elsewhere, with retinal cells, evidence has been presented 
that ephrinA1 is a potent inhibitor of epithelial and vascular endothelial cell proliferation 
(Miao et al, 2001, Ojima et al, 2006). Based on such data, it is tempting to speculate that the 
presence of ephrinA1 in the corneal endothelium may also function, along with other 
mechanisms, to sustain the low proliferative potential of this tissue. Recently, it has been 
demonstrated that ephrinA1 also influences epithelial cell migration in the human cornea via 
an interaction with EphA2 (Kaplan et al, 2012). Specifically, stimulation of EphA2 by 
ephrinA1 restricts corneal epithelial cell migration via the P13K-Akt pathway. In the current 
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investigations, evidence of EphA2 expression and EphA2 reactivity was detected in cultured 
limbal epithelial cells. Although there is evidence that an EphA2/ephrinA1 axis may play a 
role in regulating the migration of corneal epithelial cells, the potential role of ephrinA1 in 
the corneal endothelium remains to be determined. We propose that further studies utilising 
primary cultures of human corneal endothelial cells should be undertaken to investigate the 
impact of ephrinA1 on both cell proliferation and migration to see if any such functions are 
mediated via an EphA2/ephrinA1 axis.   
  
 In the present study analysis of immortalised corneal cell lines revealed the expression 
of multiple ephrinA genes. However, the only ephrinA gene expressed by both primary 
limbal stromal and epithelial cell cultures was ephrinA5. Expression of ephrinA5 was 
consistently detected in cultures of limbal epithelial cells co-cultured with murine 3T3 cells. 
By contrast, when HLE cells were cultured without 3T3 cells, evidence of ephrinA5 
expression was observed in only one donor culture. The basis for this difference is not 
known. A possibility is that the expression of ephrinA5 by HLE+3T3 co-cultures may 
represent the retention of a limbal epithelial phenotype. For example, it has been shown that 
when limbal epithelial cell cultures are established on denuded amniotic membranes the 
addition of 3T3 cells inhibits differentiation to the corneal phenotype (Grueterich et al, 2003). 
Although the potential role of ephrinA5 in the cornea remains to be determined, there is 
evidence that ephrinA5 may be fundamentally involved in establishing and maintaining 
normal tissue architecture and phenotype in other ocular structures. For example, it has been 
suggested that the regulation of cell adhesion molecules in lens cells by ephrinA5 may be 
essential for the maintenance of transparency (Cheng and Gong 2011). Specifically, 
significant disruptions to membrane-associated β-catenin and E-cadherin cell junctions and 
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increased expression of mesenchymal phenotype markers in lens cells were reported in 
ephrinA5 knockout mice.  
 
The detection of EphB4 in cells of the cornea and limbus is a further potentially 
important outcome of the present study. We observed EphB4 reactivity localised to epithelial 
cells in the limbus and cornea, the corneal endothelium and within stromal cells of the 
peripheral cornea. EphB4 expression was also detected in primary cultures of limbal stromal 
cells. However, in apparent contrast to the result obtained by immunohistochemistry, EphB4 
expression was not detected in primary cultures of limbal epithelial cells. At present the 
reason for this apparent discrepancy is unclear. However, it is important to note that the 
morphology of limbal epithelial cells in this study was significantly different when in vivo 
and in vitro model systems were compared. Specifically, in sections of human cornea, the 
epithelial cells of the limbus were typically organised into a distinctive stratified squamous 
epithelium. Here, intense EphB4 reactivity was detected at junctions between individual 
epithelial cells. By contrast, HLE cell cultures (with or without 3T3 cells) rarely contained 
areas undergoing stratification. We suggest that further studies are required to determine if 
expression of EphB4 in corneal epithelial cells is correlated with the process of stratification 
in the limbus or cornea. 
 
Detection of intense EphB4-IR in cells from the stroma of the peripheral cornea and 
in cultured HLS cells is another interesting outcome. A potential role for EphB4 in these 
peripheral stromal cells may be to provide repellent cues that help establish tissue boundaries 
or prevent blood vessels from the limbus encroaching into the cornea.  Evidence which 
supports this hypothesis has been obtained by investigations which have shown that the 
interaction of EphB4 and its key ligand (ephrinB2) mediates the positioning and migration of 
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vascular endothelial cells via repulsive cues at tissue boundaries. For example, soluble 
ephrinB2-Fc inhibits lateral cell migration, vascular endothelial growth factor (VEGF) 
gradient-driven chemotaxis, capillary-like network formation and sprouting during 
angiogenesis (Füller et al, 2003).  Stromal cells expressing EphB4 also inhibit vascular 
network formation and the proliferation of ephrinB2 expressing arterial endothelial cells 
(Zhang et al, 2001). In the current study, intense EphB4-IR was observed in cultured stromal 
cells. Findings such as these raise the possibility that interactions between EphB4-ephrinB2 
may help establish appropriate tissue boundaries in the cornea or adjacent structures.  
 
The detection of EphB6 expression by RT-PCR in immortalised corneal endothelial 
and epithelial cell lines and in primary cultures of limbal stromal cells are novel findings. The 
potential significance of EphB6 in the cornea and/or limbus, however, is unclear since it lacks 
signalling capacity due to alterations in its kinase domain. Furthermore, although in the 
current study evidence of EphB6 expression was demonstrated in HLS cells, detectable 
EphB6-IR was present in only a relatively small proportion of these cells. Further studies are 
therefore required to elucidate the potential role of EphB6 in tissues of the cornea or limbus.  
 
 In conclusion, we have demonstrated that the expression of Eph receptors and ephrin 
ligands in the human ocular surface is more widespread than previously reported. 
Specifically, evidence has been presented that Eph/ephrins are expressed by cells in all major 
tissue layers of the cornea and limbus. Of particular significance was the detection of 
Eph/ephrin expression in primary cultures of epithelial and stromal cells from the limbus 
which is widely recognised as the site of stem cells for the corneal epithelium. Moreover, our 
novel findings of expression within the corneal endothelium points to potential mechanisms 
of growth suppression in these cells in vivo. Based on the results of the current study, it can 
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be hypothesised that the Eph family of receptor tyrosine kinases and their ephrin ligands may 
play key roles in the establishment and maintenance of corneal architecture and function.  
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TABLE 1. Summary of primary antibodies used for immunohistochemistry 
 
Primary Antibody  Company (Cat #)  Species  Dilution 
Eph A1 
Eph A2 
Eph A2 
R&D systems (AF638) 
Invitrogen (34-7400) 
R&D systems (AF3035) 
Goat 
Rabbit 
Goat 
1:50 
1:50 
1:50 
Eph A3  Invitrogen (34-8500) Rabbit 1:50
Eph A4  Invitrogen (34-7900) Rabbit 1:100
ephrin A1  Invitrogen (34-3300) Rabbit 1:200
ephrin A2  Invitrogen (34-3400) Rabbit 1:50
ephrin A4 
ephrin A5  
Invitrogen (34-3700) 
R&D systems (AF3743) 
Rabbit 
Goat 
1:50 
1:50 
Eph B4   BenEphex, 
Biotechnologies (13A7) 
Mouse 1:400-1:3200 
 
Eph B4 
 
Eph B6 
BenEphex, 
Biotechnologies (C1) 
Abcam (70181) 
Mouse 
 
Rabbit 
1:400-1:3200 
 
1:50 
ephrin B1 
ephrin B2 
Invitrogen (34-3500)  
Abcam (96264) 
Rabbit 
Rabbit 
1:50 
1:50 
ephrin B3  Invitrogen (34-3600) Rabbit 1:50
Cytokeratin K3/K12  Millipore (CBL218) Mouse 1:700
∆Np63α   Biolegend (619002) Rabbit 1:100
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TABLE 2. Eph and ephrin oligonucleotide primers used for RT-PCR analysis 
 
Eph / ephrin 
(product size) 
Forward Primer Sequence Reverse Primer Sequence  
Eph A1 (197 bp)  5’CTATCATGGGCCAGTTTAGCC’3 5’GAGGTAGTTCATGCCAGATGC’3
Eph A2 (169 bp)  5’ACAACATCATCCGCCTAGAGG’3 5’TACTTCATGCCAGCTGCGATG’3
Eph A3 (138 bp)  5’GCTGCTCGGAACATCTTGATC’3 5’TGGTGATGTCCACCTGATTGG’3
Eph A4 (1013 bp)  5’GAAGGCGTGGTCACTAAATGTA’3 5’TTTAATTTCAGAGGGCGAAGAC’3
Eph A5 (200 bp)  5’CCAAATTCGAGCACGTACAGC’3 5’TTGCTTTGCTGTAGCCACACC3’ 
Eph A6 (208 bp)  5’CATTGGGGCAGGTGAATTTGG’3 5’CGGGAAGGATCTTTTGGTGAC’3
Eph A7 (223 bp)  5’AGATGGGTATTACAGGGCTCC’3 5’TCCAATGTTACTCCCACAGGG’3
Eph A8 (291 bp)  5’ACACCCAAGATGTACTGCAGC‘3 5’ACTGGAGATCAGGTTCACTGG’3
ephrin A1 (509 bp)  5’CGAATTCTGTGAGCCAAGCAG’3 5’CTGCTTGGCTCACAGAATTCG’3
ephrin A2 (184 bp)  5’GGAGAAGTTCCAGCTCTTCAC’3 5’ATTGCTGGTGAAGATGGGCTC’3
ephrin A3 (233 bp)  5’GTCTGAGGATGAAGGTGTTCG’3 5’GAACGTCATGAGGAAGAAGGC’3
ephrin A4 (155 bp)  5’CGAATTCTGTGAGCCAAGCAG’3 5’CTGCTTGGCTCACAGAATTCG’3
ephrin A5 (170 bp)  5’CTACATCTCCTCTGCAATCCC’3 5’CATGTACGGTGTCATCTGCTGG’3
Eph B1 (336 bp)  5’TGTGAGATGGACAGCTCCAGAG’3 5’TGCCACAGTCTTGAGACTTGCC’3
Eph B2 (201 bp)  5’ATGATCCGCAATCCCAACAGC’3 5’CATCATCTGAGACACGACGTC’3
Eph B3 (188 bp)  5’GATCCTACCTACACCAGTTCC’3 5’ACGGCATTGATGACATCCTGG’3
Eph B4 (250 bp)  5’CCCCAGGGAAGAAGGAGAGC’3 5’GCCCACGAGCTGGATGACTGTG’3
Eph B6 (268 bp)  5’GTGAATAGCCACTTGGTGTGC’3 5’GATGTAATCCAGGAGGACAGC’3
ephrin B1 (302 bp)  5’CAACATCCAATGGAAGCCTGG’3 5’GGAGTTGAAGAAGCCATCAGG’3
ephrin B2 (197 bp)  5’GACGTCCAGAACTAGAAGCTGG’3 5’CACCAGCGTGATGATGATGACG’3
β2-microglobulin 
(297 bp) 
5’GCTGTGCTCGCGCTACTCTCT3’ 5’AGTCACATGGTTCACACGGCAGG’3
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TABLE 3. Summary of Eph/ephrin expression profiles in immortalised cornea cell lines and 
primary cultures of limbal stromal cells (HLS) or epithelial cells (HLE; with or without 3T3 
feeder fibroblasts). +: single clear band visible. 
 
  Immortalised cell lines  Primary cell cultures   
  HCE-T  B4G12  ARPE-19  HLE  
(+ 3T3) 
HLE  HLS  3T3 
Eph/ephrin        Donor 
1  2  3 
Donor 
1  2  3 
Donor 
1  2  3 
 
Eph A1   +      +  +  +       
Eph A2  +  +  + .   +   +       
Eph A3  +  +  +        
Eph A4               
Eph A5     +  +        
Eph A6               
Eph A7               
Eph A8               
ephrin A1               
ephrin A2  +  +  +        
ephrin A3  +  +  +        
ephrin A4               
ephrin A5  +  +  + +  +  + +      + +  +  +  +
Eph B1      +        
Eph B2  +  +  +        
Eph B3               
Eph B4  +  +  +      +  +  +  +   
Eph B6  +  +        +  +  +   
ephrin B1               
ephrin B2  +  +  + +  +  + +  +  + +  +  +   
β2-
microglobulin  
+  +  + +  +  + +  +  + +  +  +   
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FIGURE LEGENDS  
 
FIGURE 1. Cytokeratin K3/K12-IR (A) or ∆Np63-IR (C) in tissue sections of human cornea 
(A). Intense cytokeratin K3/K12-IR was detected in the cytoplasm of cells of the superficial 
layers of the central corneal epithelium (arrow, A). Corresponding negative control 
(substitute primary antibody with PBS-BSA) sections of cornea (B). Bar, 30M.  ∆Np63-IR   
localised to the nuclei of cells in the basal layer of limbal epithelium (arrow, C) suggesting 
the presence of stem cells. Corresponding negative control (substitute primary antibody with 
PBS-BSA) section of limbal epithelium (D). Bar, 10M 
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FIGURE 2. Haematoxylin and eosin stained section of corneal endothelium and adjacent 
stroma (A). EphrinA-immunoreactivity in corneal endothelial cells (arrow, B). Negative 
control (ephrinA1 primary antibody substituted with PBS-BSA) (C). Bar, 30M 
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FIGURE 3. EphB4-immunoreactivity (IR) in tissue sections of human cornea and limbus. 
Haematoxylin and eosin stained sections of limbal epithelium (A), stroma of the peripheral 
cornea (B), and corneal endothelium (C). Note intense EphB4-IR localised to the junctions 
between epithelial cells (arrow, D) superficial to the basal epithelial layer. EphB4-IR in cells 
in peripheral corneal stroma (arrow, E), and corneal endothelial cells (arrow, F). Negative 
control (substitute EphB4 primary antibody with PBS-BSA) sections of limbal epithelium 
(G), peripheral corneal stroma (H), and corneal endothelium (I). Bar, 30M 
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FIGURE 4. Representative agarose gel demonstrating evidence of ephrinA5 gene expression 
(product 170bp) in immortalised HCE-T corneal epithelial (H), B4G12 corneal endothelial 
(B4) and ARPE-19 retinal pigmented epithelial (AR) cell lines. No evidence of product 
amplification was detected in corresponding negative controls (no reverse transcriptase) or 
the water blank (B). Lane M: DNA molecular weight marker X (0.075 – 12.21 kbp; Roche).  
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FIGURE 5. Appearance of primary cultures established from human limbal epithelial (A) or 
stromal (B) cells in serum supplemented medium. Cultures are shown immediately prior to 
RNA extraction. Bar, 50M.  
  
  37
 
 
FIGURE 6. Representative agarose gel demonstrating evidence of ephrinA5 expression 
(product 170bp) in cells from primary cultures of limbal epithelial (HLE) cells obtained from 
human donor eyes (n=3). For all three donor samples, endogenous ephrinA5 expression was 
detected in HLE cells co-cultured with 3T3 fibroblasts (HLE (+ 3T3)) and cultures of 3T3 
fibroblasts (3T). Evidence of ephrinA5 expression was also detected in two of the primary 
HLE cultures established without 3T3 cells (HLE (+ 3T3)). HCE-T positive control cell line 
(H). No evidence of product amplification in corresponding negative. Lanes M: DNA 
molecular weight marker X (0.075 – 12.21 kbp; Roche). Lanes B: water blanks.  
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FIGURE 7. Composite images from separate gels comparing PCR amplification of 
Eph/ephrins from donor human limbal epithelial (HLE) or stromal cells (HLS). HLE cultures 
were prepared with or without 3T3 fibroblasts. Only results where expression of Eph/ephrin 
genes was detected in limbal cells are presented. Positive control samples were either the 
HCE-T cell line (for EphA1, B6; ephrin B2) or the pooled sample of prostate cell lines (for 
EphA2, B4; ephrin A5). 
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FIGURE 8. Immunolocalisation of Eph/ephrin-IR in primary HLE+3T3 cultures.  Diffuse 
extranuclear immunoreactivity for EphA1 (C) ephrinA5 (E) and ephrinB2 (F) was detected in 
HLE cells, with reactivity most evident where small clusters of confluent epithelial cells had 
formed. Intense EphA2-IR was also detected at epithelial cell borders (arrow D, 2x insert). 
Negative controls using either the Alexa Fluor 488 anti-goat (A) or 594 anti-rabbit (B) antibodies 
displayed negative staining. Bar, 250 . 
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FIGURE 9. Immunolocalisation of Eph/ephrin-IR in primary HLS cultures. Intense 
extranuclear immunoreactivity for EphB4 (D) and ephrinA5 (F) was widely detected in 
primary HLS cells. By contrast, only limited evidence of EphB6-IR was detected in HLS 
cultures (E). Closer examination revealed EphB6-IR in HLS cells was extranuclear (E, 2x 
insert). No evidence of ephrinB2 reactivity was detected in cultured HLS cells (G) Negative 
controls using either the Alexa Fluor 488 anti goat (A) mouse (B) or 594 anti-rabbit (C) displayed 
negative staining. Bar, 250 . 
 
